Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Reeves

Showing results (481-490 of 537) with videos related to

Pageof 54
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2002
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kineticsJacqueline D Reeves, Stephen A Gallo, Navid Ahmad, et al.
Journal of Virology|March 16, 2004
Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptorsStefan Pöhlmann, Carl Davis, Silke Meister, et al.
Journal of Geophysical Research. Space Physics|April 23, 2019
A Revised Look at Relativistic Electrons in the Earth's Inner Radiation Zone and Slot RegionS G Claudepierre, T P O'Brien, M D Looper, et al.
The Journal of Infectious Diseases|October 23, 2024
Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti-HIV-1 AntibodiesMarie Høst Pahus, Yu Zheng, Maxine Olefsky, et al.
Science (New York, N.Y.)|October 10, 1997
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokinesC Boshoff, Y Endo, P D Collins, et al.
Virology|December 31, 2002
DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cellsGraham Simmons, Jacqueline D Reeves, Case C Grogan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosisJ A Wilken, R Kane, C L Sullivan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 15, 2025
Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults with HIV-1: ACTG A5357Babafemi O Taiwo, Yu Zheng, Katherine Rodriguez, et al.
Organic & Biomolecular Chemistry|July 3, 2014
Conversion of S-phenylsulfonylcysteine residues to mixed disulfides at pH 4.0: utility in protein thiol blocking and in protein-S-nitrosothiol detectionB D Reeves, N Joshi, G C Campanello, et al.
Journal of Virology|August 20, 2010
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistanceBrett D Welch, J Nicholas Francis, Joseph S Redman, et al.
Pageof 54

Showing results (481-490 of 537) with videos related to

Sort By:
Pageof 54
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2002
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kineticsJacqueline D Reeves, Stephen A Gallo, Navid Ahmad, et al.
Journal of Virology|March 16, 2004
Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptorsStefan Pöhlmann, Carl Davis, Silke Meister, et al.
Journal of Geophysical Research. Space Physics|April 23, 2019
A Revised Look at Relativistic Electrons in the Earth's Inner Radiation Zone and Slot RegionS G Claudepierre, T P O'Brien, M D Looper, et al.
The Journal of Infectious Diseases|October 23, 2024
Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti-HIV-1 AntibodiesMarie Høst Pahus, Yu Zheng, Maxine Olefsky, et al.
Science (New York, N.Y.)|October 10, 1997
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokinesC Boshoff, Y Endo, P D Collins, et al.
Virology|December 31, 2002
DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cellsGraham Simmons, Jacqueline D Reeves, Case C Grogan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosisJ A Wilken, R Kane, C L Sullivan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 15, 2025
Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults with HIV-1: ACTG A5357Babafemi O Taiwo, Yu Zheng, Katherine Rodriguez, et al.
Organic & Biomolecular Chemistry|July 3, 2014
Conversion of S-phenylsulfonylcysteine residues to mixed disulfides at pH 4.0: utility in protein thiol blocking and in protein-S-nitrosothiol detectionB D Reeves, N Joshi, G C Campanello, et al.
Journal of Virology|August 20, 2010
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistanceBrett D Welch, J Nicholas Francis, Joseph S Redman, et al.
Pageof 54